Bloomberg the Company

Bloomberg Anywhere Login

Bloomberg

Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.

Company

Financial Products

Enterprise Products

Media

Customer Support

  • Americas

    +1 212 318 2000

  • Europe, Middle East, & Africa

    +44 20 7330 7500

  • Asia Pacific

    +65 6212 1000

Follow Us

Industry Products

Businessweek Archives

Will U.S. Biotech Mutate Into Another Lost Market?


Developments to Watch

WILL U.S. BIOTECH MUTATE INTO ANOTHER LOST MARKET?

Amid the gloom over declining U.S. competitiveness in everything from autos to electronics, biotechnology stands out as a strength. But even this is fodder for Cassandras. "Unless concrete steps are taken by government, industry, and universities," warns a new report from the prestigious National Academy of Sciences, the "U.S. biotechnology industry will lose its strong leadership position."

In particular, the authors are worried about an increasing one-way technology flow from the U.S. to Japan. In nearly 300 cases of links between companies of the two countries, for example, they found that more than 90% involve a transfer to Japan. In addition, Japanese companies are funding millions of dollars of research in academia. And thousands of Japanese scientists participate in cutting-edge research at U.S. universities, then take the knowledge home.

The report concludes that U.S. companies, universities, and the government must develop strategies "to increase inflows of technology from Japan and to expand marketing and sales in Japan." Examples include tapping Japan's strength in biotech manufacturing and better monitoring of advances there.EDITED BY FLEUR TEMPLETON


LIMITED-TIME OFFER SUBSCRIBE NOW
 
blog comments powered by Disqus